ODYY (Odyssey Health) Tariff Resilience Score: 5/10 (As of Jul. 06, 2026)


What is Odyssey Health Tariff Resilience Score?

Odyssey Health ODYY +8.00% Tariff Resilience Score is 5 as of Jul. 06, 2026. The stock has 4 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Odyssey Health ranks better than 79.21% on this metric.

Odyssey Health has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Odyssey Health has Odyssey Group International Inc has moderate exposure to tariffs due to its reliance on imported materials. However, it has been actively seeking alternative suppliers and has some pricing power in niche markets, which provides partial mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Odyssey Health might have Average Resilient.

Odyssey Health  (OTCPK:ODYY) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Odyssey Health Tariff Resilience Score Related Terms

ODYY vs SSKN, NUMD, PFSA: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Odyssey Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Odyssey Health Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Odyssey Health's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
Odyssey Health (ODYY) has a Tariff Resilience Score of 5 as of Jul. 06, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Odyssey Health ranks #174 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is Odyssey Health's Tariff Resilience Score too high?
Odyssey Health's current Tariff Resilience Score is 5. Based on the distribution chart, Odyssey Health ranks #174 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Odyssey Health's Tariff Resilience Score compare to SSKN and NUMD?
According to the Medical Devices & Instruments industry distribution chart, Odyssey Health ranks #174 out of 837 companies for Tariff Resilience Score. This places Odyssey Health in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Odyssey Health's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Odyssey Health (ODYY), the current Tariff Resilience Score is 5 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Health Business Description

Address 2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.